5paisa capital has announced the outcome of its board meeting held on March 11, 2026, finalizing the comprehensive terms of its rights issue following the initial approval granted on February 24, 2026. The company will raise ₹4,688.23 million through the issuance of 15,627,419 fully paid-up equity shares at ₹300 per share, including a premium of ₹290 per share.

Rights Issue Structure and Pricing

The board has determined the complete framework for the rights issue, setting competitive terms for existing shareholders. The issue will follow a 1:2 entitlement ratio, meaning eligible shareholders will receive one rights equity share for every two fully paid-up equity shares held as on the record date.

Timeline and Key Dates

The company has established a comprehensive timeline for the rights issue process, ensuring adequate time for shareholder participation. The record date has been set for March 17, 2026, to determine eligible shareholders, with the issue opening on March 27, 2026.

Share Capital Impact

The rights issue will significantly expand the company's equity base, with outstanding equity shares increasing from 31,254,838 shares to 46,882,257 shares, assuming full subscription. This represents a substantial capital infusion that will strengthen the company's financial position.

Regulatory Approvals and Compliance

The company has received in-principle approvals from both BSE Limited and National Stock Exchange of India Limited on March 05, 2026, for the proposed rights issue. The announcement has been made in compliance with Regulation 30 of the SEBI Listing Regulations, with the board meeting conducted from 07:30 PM to 08:30 PM IST on March 11, 2026.

The rights issue will be conducted in accordance with the Companies Act, 2013, SEBI Issue of Capital and Disclosure Requirements Regulations, 2018, and other applicable laws. Off-market renunciation will be permitted, with shareholders required to ensure completion prior to the issue closing date. The board and rights issue committee retain the right to extend the issue closing date, subject to the issue period not exceeding 30 days from the opening date.

5paisa capital Limited has announced that it has received a Certificate of Registration as a Research Analyst from the Securities and Exchange Board of India (SEBI). The approval was communicated through SEBI's email dated February 26, 2026, with the company making the disclosure on February 27, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Registration Details

The registration certificate has been granted under the SEBI (Research Analysts) Regulations, 2014, which will enable the company to undertake and carry on activities as a Research Analyst in accordance with applicable regulations.

Business Impact

According to the company's disclosure, this registration is expected to support 5paisa Capital's business activities by allowing it to conduct research analyst operations. The certificate enables the company to expand its service offerings within the regulatory framework established by SEBI for research analysts.

Regulatory Compliance

The certificate is valid for a period of five years from the date of grant of registration, subject to payment of applicable renewal fees as prescribed under the SEBI (Research Analysts) Regulations, 2014. The company has made this disclosure in compliance with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Key Features

• Registration allows research analyst activities under SEBI regulations
• Five-year validity period with renewal option
• Expected to enhance the company's business capabilities
• Full compliance with SEBI disclosure requirements

The disclosure was signed by Charvi Panchmatia, Company Secretary & Compliance Officer, and submitted to both BSE Limited and the National Stock Exchange of India Limited as required under the listing regulations.